AngioDynamics recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the AlphaVac mechanical thrombectomy system.
According to a company press release, AlphaVac is an off-circuit, multipurpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature.
AngioDynamics continues to anticipate the commercial release of the AlphaVac system in the second half of calendar year 2021.
